Dosing equivalency of second-generation antipsychotic medications [4] (multiple letters)

Journal of Clinical Psychopharmacology

Volumn 25, Issue 5, 2005, Pages 501-504

  Buckley, Peter F ^a   Davis, John M ^b,c   Chen, Nancy ^b,c   Walker, Jill Kerrick ^d   Herman, Barry K ^d   Loebel, Antony ^d  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c MARYLAND PSYCHIATRIC RESEARCH CENTER   (United States)

^d PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; NEUROLEPTIC AGENT; OLANZAPINE; RISPERIDONE; ZIPRASIDONE;

AGITATION; ANXIETY DISORDER; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; HUMAN; LETTER; PRIORITY JOURNAL; PSYCHOSIS; SIDE EFFECT; TREATMENT OUTCOME;

ANTIPSYCHOTIC AGENTS; DATA COLLECTION; HUMANS; PSYCHOTIC DISORDERS;

EID: 25444461476     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000178413.37556.6c     Document Type: Letter

References (0)